05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
Individual employment agreements cannot provide for penalty clauses for the breach of the employees’...
Read More >
Setting clear and reasonable standards for taking access to an employer’s private property is high ...
Read More >
- On April 16, 2020, the Chinese competition authority finally announced its conditional approval of...
Read More >
Under the federal Uniformed Services Employment and Reemployment Rights Act (USERRA), employers are ...
Read More >
In today’s edition of Daily Compliance News: • Just who are your friends and why does it matter. (...
Read More >
Employers across the world are responding to the developing information on the coronavirus (referred...
Read More >